Skip to main content

abrdn Life Sciences Investors

HQL
Exchange
NYSE
SEC CIK
0000884121

In the last 90 days, abrdn Life Sciences Investors insiders filed 1 open-market purchase and 0 sales; 84 institutions reported holding it in 13F filings for Q2 2026, worth $156.5M in total; no superinvestor holds it.

Q1 2024 vs. Q4 2023

How the institutions holding abrdn Life Sciences Investors changed between Q4 2023 and Q1 2024.

All holders in Q1 2024All holders in Q4 2023

13F holders of HQL: Q4 2023 compared with Q1 2024
MeasureQ4 2023Q1 2024Change
Holders79790
Shares7.96M9.10M+1.14M (+14.3%)
Value$107.2M$124.0M+$16.8M (+15.7%)

New holders (13)

Institutions that held abrdn Life Sciences Investors at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to HQL in Q1 2024
InstitutionSharesValue% of portfolio
Absolute Investment Advisers LLC598,408$8.16M1.11%
Karpus Management, Inc.345,518$4.71M0.14%
KPP Advisory Services LLC23,932$326.2K0.09%
Two Sigma Investments, LP23,540$320.9K0.00%
Invesco Ltd.21,044$286.8K0.00%
The PNC Financial Services Group, Inc.13,315$181.5K0.00%
National Asset Management, Inc.11,500$143.4K0.00%
First Trust Advisors LP10,448$142.4K0.00%
Eudaimonia Partners, LLC10,434$142.2K0.03%
CIBC Private Wealth Group, LLC2,469$33.3K0.00%
Future Financial Wealth Managment LLC2,000$27.3K0.02%
CoreCap Advisors, LLC884$12.0K0.00%
Huntington National Bank–$7240.00%

Sold out (13)

Institutions that held abrdn Life Sciences Investors at the end of Q4 2023 and filed for Q1 2024 without it.